Prof. MD. Duygu Derin

Prof. MD.

Duygu Derin

Medical Oncology
Single Form Doctors

Areas of Interests

  • Breast Cancer
  • Colon Cancer
  • Lung Cancer
  • Ovary Cancer
22

International
Articles

77

h-index

Education and Experiences
  • 2016 – Currently: Liv Hospital Ulus Hospital
  • Medical Oncologist in Neolife Oncology Center
  • Assoc. Prof. of Medical Oncology in 2010 
  • Medical Oncologist in İstanbul American Hospital in 2009-2010   
  • Compulsory Service in Kayseri Training and Research Hospital between 2006-2008 
  • Medical Oncology specialisation in İstanbul University İstanbul Medical Faculty  Onkology Institute in 2003-2006 
  • Internal Diseases specialisation in Taksim Training and Research Hospital in 2001 
  • Graduation from İstanbul University İstanbul Medical Faculty in 1993 
  • Graduation from Galatasaray Lycee in 1987
22

International
Articles

77

h-index

Education and Experiences
  • 2016 – Currently: Liv Hospital Ulus Hospital
  • Medical Oncologist in Neolife Oncology Center
  • Assoc. Prof. of Medical Oncology in 2010 
  • Medical Oncologist in İstanbul American Hospital in 2009-2010   
  • Compulsory Service in Kayseri Training and Research Hospital between 2006-2008 
  • Medical Oncology specialisation in İstanbul University İstanbul Medical Faculty  Onkology Institute in 2003-2006 
  • Internal Diseases specialisation in Taksim Training and Research Hospital in 2001 
  • Graduation from İstanbul University İstanbul Medical Faculty in 1993 
  • Graduation from Galatasaray Lycee in 1987
Research
  • A phase 3 study of the new Epatilon BMS247550+capesitabine in patients with advanced breast cancer previously treated with an anthracycline or taxane. Prot no: CA163048. Coordination center: Hacettepe Medical Faculty. Responsible coordinator: Prof. Dr. Esmen Baltaci. Co-investigator: Dr. Duygu Derin
  • A phase 3 randomized placebo-controlled double-blind study comparing oral CCI-779 in combination with letrozole versus letrozole alone in first-line hormone therapy in postmenopausal women with locally advanced or metastatic breast carcinoma. Prot no: 3066A1-303WW. Coordination center: Istanbul University Oncology Institute. Responsible coordinator: Prof.Dr. Pınar Saip. Co-investigator: Dr. Duygu Derin
Publications
  • Soydinc, H.O., Duranyildiz, D., Guney, N., Derin, D., Yasasever, V. ”Utility of serum and urine uPAR levels for diagnosis of breast cancer. Asian Pac J Cancer Prev. 2012;13(6):2887-9.
  • Vural, B., Yakar, F., Derin, D., Saip, P., Yakar, A., Demirkan, A., Karabulut, A., Ugurel, E., Cine, N., Kilicaslan, Z., Tüzün, E., Ozbek, U. ”Küçük hücreli akciğer kanserli hastalarda glutatyon S-transferaz P1 polimorfizmlerinin (Ile105Val ve Ala114Val) değerlendirilmesi. Genet Test Mol Biomarkers. 2012 Jul;16(7):701-6. doi: 10.1089/gtmb.2011.0315. Epub 2012 Feb 17.
  • Saip, R., Sen, F., Vural, B., Ugurel, E., Demirkan, A., Derin, D., Eralp, Y., Camlica, H., Ustuner, Z., Ozbek, U. ”Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients. J BUON. 2011 Apr-Jun;16(2):241-6.
  • Ozluk, Y., Kilicaslan, I., Kazancioglu, R., Demirkesen, C., Derin, D., Mandel, N.M. ”Intraglomerular crescentic metastases of malignant melanoma. Hum Pathol. 2011 Dec;42(12):2025-8. doi: 10.1016/j.humpath.2010.05.032. Epub 2011 Jun 12.
  • Beyazıt, H., Aydın, O., Demirkesen, C., Derin, D., Süt, P., Emre, A., Mandel,N. ”Gastrik adenokarsinom seyri sırasında pankreas tutulumunun ilk belirtisi olarak pankreatik pannikülit” Med Oncol. 2011 Mar;28(1):137-9. doi: 10.1007/s12032-010-9420-8. Epub 2010 Jan 30.
  • Bitisik, O., Saip, P., Saglam, S., Derin, D., Dalay, N. ”Mammaglobin and maspin transcripts in blood may reflect disease progression and treatment effect in breast cancer. Genet Mol Res. 2010;9(1):97-106.
  • Basaran, G., Okkan, S., Çaglar, H., Benekli, M., Gümüş, M., Haydaroğlu , A., Eralp, Y., Abalı, H., Yıldız, F., Bese, N., Gursel, B., Guney, N., Derin, D. ”Immunohistochemically Defined T1N0 Breast Cancer SungroupsHave Different Clinical Outcomes. A Retrospective Turkish Oncology Group Study. ” Cancer Research 02/2010 69(24 supplement) 3167-3167 DOI: 10.11580008-5472 SABCS-09-3167
  • Can, G., Topuz, E., Derin, D., Durna, Z., Aydıner, A. ”The effect of kefir on quality of life in colorectal cancer patients. Oncol Nurs Forum. 2009 Nov;36(6):E335-42. doi: 10.1188/09.ONF.E335-E342.
  • Guney, N., Soydinc, H.O., Basaran, M., Bavbek, S, Derin, D., Camlica, H., Yasasever, V., Topuz, E. ”Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin’s lymphoma. Asian Pac J Cancer Prev. 2009 Oct-Dec;10(4):669-74.
  • Guney, N., Sayilgan, T., Derin, D., Ozcan, D. ”Primary carcinoid tumor arising in mature cystic teratoma of the ovary: a case report”. Eur J Gynaecol Oncol. 2009;30(2):223-5.
  • Medical Oncology Society 
  • Chamber of Medicine
  • Galatasaraylılar Fan Society
  • Turkish Cancer Research and Warfare Organization (XVIIth National Cancer Congress) Oncology Research Second Prize: Oguzsoydinç,H., Çamlıca, H., Duranyılmaz, D., Güney, N., Derin, D., Taş, F., Dalay, N., Yasasever, V. “The Utility of the Serum and Urine UPAR Levels in Breast Cancer”